July 1, 2020
Health Canada lets certain COVID-19 patients to take NuvOx Pharma’s Oxygen therapeutic in phase II clinical trial (edit)
NuvOx Pharma ensured the continuation of Phase 2 clinical trial of its NanO2 in Covid-19 patients with acute hypoxic respiratory failure, as it got No Objection Letter from Health Canada.